Close Menu
NEW YORK (GenomeWeb News) - Although 23andMe had kept mum for several months on which contract laboratory it has been using to conduct its DTC genomic testing services, GenomeWeb Daily News has learned that Laboratory Corporation of America is providing the necessary genotyping services for the personal genomics company.
 
Officials from both 23andMe and LabCorp have confirmed that the lab testing giant is providing the genotyping services for 23andMe's service.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.